NCT05641571

Brief Summary

The purpose of this study is to examine the effects of an exercise program on the management of TIPN in breast cancer survivors. This experimental study utilizes purposive sampling to recruit 88 adults, newly diagnosed with stage I\~III breast cancer women, who are expected to be treated with Taxane chemotherapy in a medical center located in central Taiwan. Participants will be randomly allocated to the experimental or observational group. The main outcomes are peripheral neuropathy and neuropathic pain. The 3\~6 months home-based extremity exercise program will be intervened between newly diagnosed with breast cancer to the completion of chemotherapy. Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time. This study expects that the extremity exercise program will be able to prevent and manage peripheral neuropathy and neuropathic pain via increasing blood circulation. Moreover, the exercise program may also improve functioning and QOL in breast cancer survivors receiving Taxane chemotherapy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 7, 2022

Status Verified

November 1, 2022

Enrollment Period

1.1 years

First QC Date

October 26, 2022

Last Update Submit

November 30, 2022

Conditions

Keywords

Taxane-induced peripheral neuropathy, extremity exercise

Outcome Measures

Primary Outcomes (1)

  • The incidence and severity of peripheral neuropathy

    Total Neuropathy Score- clinical version, pain 0\~100 Visual Analogue Scale, Identification Pain Questionnaire

    Change of peripheral neuropathy from baseline measure at 6 months

Secondary Outcomes (1)

  • The score change in quality of life

    Change of quality of life from baseline measure at 6 months

Study Arms (2)

Exercise group

EXPERIMENTAL

The 3\~6 months home-based extremity exercise program will be intervened between newly diagnosed with breast cancer to the completion of chemotherapy. Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time.

Behavioral: The home-based extremity exercise program

Observational group

NO INTERVENTION

The observational group will need to record the extra exercise performed and the exercise prescription will be distributed after the study.

Interventions

Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time before chemotherapy to the completion of chemotherapy.

Exercise group

Eligibility Criteria

Age20 Years - 99 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be randomly allocated to the experimental or observational group using the two strata: (1) adjuvant or neoadjuvant and (2) paclitaxel, docetaxel, or Taxane plus Platinum.

You may not qualify if:

  • Participants who have peripheral neuropathy before chemotherapy or regular exercise are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Wang YJ, Hung MC, Wu CJ, Huang CC, Cao HW. Effects of an exercise program on chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer individuals receiving taxanes: a randomized controlled trial. Support Care Cancer. 2025 Nov 10;33(12):1036. doi: 10.1007/s00520-025-10121-8.

Study Officials

  • Chih-Chiang Hung, Doctor

    Taichung Veterans General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ya-Jung Wang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The 3\~6 months home-based extremity exercise program will be intervened between newly diagnosed with breast cancer to the completion of chemotherapy. Participants have to perform a total of 50 minutes of exercise including the Ten Skilled Hand exercise fourth a day, 5 minutes each time and Buerger Allen exercise twice a day, 15 minutes each time. The observational group will need to record the extra exercise performed and the exercise prescription will be distributed after the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2022

First Posted

December 7, 2022

Study Start

December 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

December 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share